Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.321,86
-0,48%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bioAffinity Technologies Inc (BIAFW) bioAffinity Technologies Inc (BIAFW) Notizie

BIAFW

bioAffinity Technologies (BIAFW)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAFW
DataOraFonteTitoloSimboloCompagnia
15/06/202402:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
12/06/202414:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFWbioAffinity Technologies Inc
05/06/202422:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIAFWbioAffinity Technologies Inc
05/06/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFWbioAffinity Technologies Inc
22/05/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
15/05/202416:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFWbioAffinity Technologies Inc
15/05/202415:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFWbioAffinity Technologies Inc
02/05/202414:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
24/04/202414:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFWbioAffinity Technologies Inc
09/04/202414:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFWbioAffinity Technologies Inc
01/04/202415:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
08/03/202418:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
06/03/202415:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
30/01/202414:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFWbioAffinity Technologies Inc
08/01/202414:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFWbioAffinity Technologies Inc
05/12/202314:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFWbioAffinity Technologies Inc
30/11/202314:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFWbioAffinity Technologies Inc
28/11/202314:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFWbioAffinity Technologies Inc
14/11/202322:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
06/11/202314:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFWbioAffinity Technologies Inc
10/10/202314:00Business WirebioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
07/09/202314:00Business WirebioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
14/08/202323:03Business WirebioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
12/07/202314:00Business WireAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerNASDAQ:BIAFWbioAffinity Technologies Inc
15/06/202314:00Business WirebioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
22/05/202314:00Business WirebioAffinity Technologies Presents Research Findings at CYTO 2023NASDAQ:BIAFWbioAffinity Technologies Inc
01/05/202314:00Business WirebioAffinity Technologies Names Michael Dougherty as Chief Financial OfficerNASDAQ:BIAFWbioAffinity Technologies Inc
25/04/202314:00Business WirebioAffinity Technologies Presents at Cleveland Clinic Lung Cancer SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
31/03/202323:52Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAFW

La tua Cronologia

BIT
UNIR
Unieuro
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network